News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hutchison Medipharma Starts Clinical Trial of Second Cancer Drug


2/1/2011 12:34:59 PM

February 1, 2011 -- Hutchison MediPharma, the drug discovery arm of Chi-Med, has begun a Phase I trial of its second anti-angiogenesis cancer drug candidate, fruquintinib. The first molecule, sulfatinib (HMPL-012), began clinical trials in April of 2010. According to Hutchison, fruquintinib showed “potent” anti-angiogenesis activity in pre-clinical testing. More details....

Read at BioSpace.com
Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES